KRAS and colorectal carcinoma: In CRC, a high prevalence of KRAS mutations correlates with chronic inflammatory diseases, and TP53 mutations contribute to immune surveillance, angiogenesis and remodeling of the extracellular matrix (Michel et al., 2021; Nenkov et al., 2021; Pereira et al., 2022).